Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
The European Commission clears Johnson & Johnson’s $21.3 billion buyout of orthopedics giant Synthes after J&J agrees to ditch its DePuy trauma operation to Biomet.
The U.S. House version of a bill reauthorizing FDA review user fees would add employment and economic considerations to the federal watchdog agency’s mission statement.
Will support for repealing the medical device tax repeal from Elizabeth Warren, who’s dazzled liberals and raised big bucks from left-wing groups across the country in her run for the U.S. Senate, help generate more support among Democrats for killing the medical device tax?